Market Research

907 responses in six countries were received. 43 hospitals used UltraSafe^® Needle Guards for at least three months. 91% of nurses expressed a high concern about safety; 85% said UltraSafe^® Needle Guards satisfied this concern. They requested that drug manufacturers pre-attach the UltraSafe^® needle guard.

158 nurses were interviewed in 15 hospitals in six countries. The nurses identified the UltraSafe Passive^® delivery system advantages to be safety and ease of use. 100% felt that patients could self-inject with it; 98% said there was a clear need at their hospital and that they would purchase the UltraSafe Passive^® delivery system.

When asked to compare four safety devices with differing modes of activation, 86% preferred one-handed devices and 55% preferred the UltraSafe Passive^® Delivery System. BD SafetyGlide^™ was the least preferred device by 60%.

In interviews, this study found that the Luer lock UltraSafe Passive^® Delivery System was preferred over two other Luer lock safety needles by 74%. Nurses unanimously preferred a staked needle over Luer lock; 100% favored a prefilled syringe rather than a vial.

94.3% of nurses preferred the UltraSafe Passive ^® delivery system over BD Preventis; all activated the Safety Syringes product appropriately with no training.

37 multiple sclerosis(MS) patients and 21 rheumatoid arthritis(RA) patients were interviewed. All users said a high level of safety is important. 100% of the RA patients/92% of the MS patients found the UltraSafe Passive^® delivery system easy to use; 74% of the MS patients/71% of the RA patients said they would choose the UltraSafe Passive^® delivery system over their current delivery device.